library (readxl)
library (readr)
library (tidyverse)
── Attaching core tidyverse packages ──────────────────────── tidyverse 2.0.0 ──
✔ dplyr 1.1.4 ✔ purrr 1.0.2
✔ forcats 1.0.0 ✔ stringr 1.5.1
✔ ggplot2 3.4.4 ✔ tibble 3.2.1
✔ lubridate 1.9.3 ✔ tidyr 1.3.1
── Conflicts ────────────────────────────────────────── tidyverse_conflicts() ──
✖ dplyr::filter() masks stats::filter()
✖ dplyr::lag() masks stats::lag()
ℹ Use the conflicted package (<http://conflicted.r-lib.org/>) to force all conflicts to become errors
library (tidyr)
library (dplyr)
library (lme4)
Warning: package 'lme4' was built under R version 4.3.3
Loading required package: Matrix
Attaching package: 'Matrix'
The following objects are masked from 'package:tidyr':
expand, pack, unpack
library (emmeans)
library (rstanarm)
Loading required package: Rcpp
Warning: package 'Rcpp' was built under R version 4.3.3
This is rstanarm version 2.32.1
- See https://mc-stan.org/rstanarm/articles/priors for changes to default priors!
- Default priors may change, so it's safest to specify priors, even if equivalent to the defaults.
- For execution on a local, multicore CPU with excess RAM we recommend calling
options(mc.cores = parallel::detectCores())
library (ggplot2)
library (effects)
Loading required package: carData
Warning: package 'carData' was built under R version 4.3.3
lattice theme set by effectsTheme()
See ?effectsTheme for details.
Warning: package 'car' was built under R version 4.3.3
Attaching package: 'car'
The following object is masked from 'package:rstanarm':
logit
The following object is masked from 'package:dplyr':
recode
The following object is masked from 'package:purrr':
some
##Make other dataframes
#df <- df %\>% mutate(feedback.ACC = as.numeric(feedback.ACC))
##Only include response procedre entires
T_B_R <- T_B %>% filter (procedure == "responsprocedure" )
##Create trial numbers
df <- T_B_R %>%
group_by (session, subject) %>%
mutate (trial = rep (1 : 48 , each = case_when (
session == 1 ~ 6 ,
session == 2 ~ 12 ,
session == 18 ~ 18 ,
TRUE ~ n () / 48 # Default: dynamically calculate N per trial
))[1 : n ()]) %>% # Ensures correct length
ungroup ()
Warning: There were 55 warnings in `mutate()`.
The first warning was:
ℹ In argument: `trial = ...[]`.
ℹ In group 1: `session = 1` and `subject = 2`.
Caused by warning in `rep()`:
! first element used of 'each' argument
ℹ Run `dplyr::last_dplyr_warnings()` to see the 54 remaining warnings.
##Create Trial Accuracy
df <- df %>% mutate (feedback.ACC = as.numeric (feedback.ACC), feedback.RT = as.numeric (feedback.RT))
df <- df %>%
group_by (subject, session, trial) %>%
mutate (trial.acc = sum (feedback.ACC, na.rm = TRUE ) / n ()) %>%
ungroup ()
##Make trial avhg RT
df <- df %>%
group_by (subject, session, trial) %>%
mutate (trial.RT = sum (feedback.RT, na.rm = TRUE ) / n ()) %>%
ungroup ()
write.csv (df,"Philipp_df.csv" , row.names = FALSE )
##Make dataframe with only above 80% trial accuracy
df_acc <- df %>% filter (trial.acc >= 1 ) %>% mutate (subject= as.factor (subject))
df_acc5 <- df_acc %>% distinct (subject,trial,session) %>% count (subject, name = "corr_trials" )
Q_D[6 , "Weight" ] <- 62
Q_D <- Q_D %>% rename ( subject = ID)
Q_D <- Q_D %>% filter (subject != 6 , subject != 9 )
Q_D <- Q_D %>% mutate (subject = as.factor (subject),Sequence= as.factor (Sequence))
df_BMI<- Q_D %>% select (subject,"Height" , "Weight" ) %>% mutate (BMI= (Weight)/ ((Height/ 100 )* (Height/ 100 ))) %>% select (- "Height" ,- "Weight" )
df_acc<- df_acc %>% left_join (df_BMI, by= "subject" ) %>% left_join (df_acc5, by= "subject" )
##Qestionaire Data merge with rest
Part <- df %>% mutate (subject = as.factor (subject))
Part <- Part %>% left_join (Q_D, by = "subject" )
Part <- Part %>% mutate (session= as.factor (session), sub.trial.number = as.factor (sub.trial.number))
df_subset <- Q_D %>% select (18 , 36 : 71 )
df_subset2 <- Q_D %>% select (18 , 27 : 71 )
df_sequence <- Q_D %>% select (18 ,19 )
df_subset <- df_subset %>%
mutate (across (matches ("^[A-Za-z0-9]+_[0-9]+$" ), as.character))
df_q_long <- df_subset %>%
pivot_longer (
cols = - subject, # All columns except subject
names_to = c ("variable" , "session" ), # Split names into 'variable' and 'session'
names_sep = "_" ,
values_to = c ("value" )# Use underscore as the separator
) %>% pivot_wider (names_from = variable,
values_from = value) %>% mutate (session = as.factor (session))
df<- df %>% mutate (subject= as.factor (subject),session= as.factor (session))
df_after_session_qestionaire <- df %>% left_join (df_q_long, c ("subject" , "session" )) %>% mutate (Q1 = as.numeric (Q1), Q2 = as.numeric (Q2),Q3 = as.numeric (Q3),Q4 = as.numeric (Q4),Q5 = as.numeric (Q5),Q6 = as.numeric (Q6),x = as.numeric (x),y = as.numeric (y)) %>% left_join (df_sequence, by= "subject" )
df_after_session_qestionaire <- df_after_session_qestionaire %>% rename (mental_demand = Q1,physical_demand = Q2,temporal_demand = Q3,performance = Q4,effort = Q5,frustration = Q6)
#Does remembering the sequence correctly have an significant influence on performance
M_CB<- lmer (trial.RT ~ 0 + Sequence + (1 | subject) + (1 | session) + (1 | trial), data= df_after_session_qestionaire)
summary (M_CB)
Linear mixed model fit by REML ['lmerMod']
Formula: trial.RT ~ 0 + Sequence + (1 | subject) + (1 | session) + (1 |
trial)
Data: df_after_session_qestionaire
REML criterion at convergence: 432174.8
Scaled residuals:
Min 1Q Median 3Q Max
-4.1976 -0.5135 -0.0980 0.3317 20.5982
Random effects:
Groups Name Variance Std.Dev.
trial (Intercept) 5032.0 70.94
subject (Intercept) 54167.4 232.74
session (Intercept) 118.1 10.87
Residual 43181.4 207.80
Number of obs: 31968, groups: trial, 48; subject, 19; session, 3
Fixed effects:
Estimate Std. Error t value
Sequence1 550.4 134.9 4.079
Sequence2 451.2 134.9 3.344
Sequence3 457.7 165.0 2.773
Sequence4 686.2 165.0 4.158
Sequence5 943.1 165.0 5.714
Sequence6 431.3 165.0 2.613
Sequence7 571.7 135.0 4.236
Sequence8 422.6 165.0 2.561
Correlation of Fixed Effects:
Seqnc1 Seqnc2 Seqnc3 Seqnc4 Seqnc5 Seqnc6 Seqnc7
Sequence2 0.008
Sequence3 0.006 0.006
Sequence4 0.006 0.006 0.005
Sequence5 0.006 0.006 0.005 0.005
Sequence6 0.006 0.006 0.005 0.005 0.005
Sequence7 0.008 0.008 0.006 0.006 0.006 0.006
Sequence8 0.006 0.006 0.005 0.005 0.005 0.005 0.006
posthoc1 <- emmeans (M_CB, ~ Sequence)
Note: D.f. calculations have been disabled because the number of observations exceeds 3000.
To enable adjustments, add the argument 'pbkrtest.limit = 31968' (or larger)
[or, globally, 'set emm_options(pbkrtest.limit = 31968)' or larger];
but be warned that this may result in large computation time and memory use.
Note: D.f. calculations have been disabled because the number of observations exceeds 3000.
To enable adjustments, add the argument 'lmerTest.limit = 31968' (or larger)
[or, globally, 'set emm_options(lmerTest.limit = 31968)' or larger];
but be warned that this may result in large computation time and memory use.
pairwise_comparisons1 <- pairs (posthoc1)
summary (pairwise_comparisons1)
contrast estimate SE df z.ratio p.value
Sequence1 - Sequence2 99.27 190 Inf 0.522 0.9996
Sequence1 - Sequence3 92.72 213 Inf 0.436 0.9999
Sequence1 - Sequence4 -135.78 213 Inf -0.639 0.9983
Sequence1 - Sequence5 -392.66 213 Inf -1.848 0.5872
Sequence1 - Sequence6 119.16 213 Inf 0.561 0.9993
Sequence1 - Sequence7 -21.28 190 Inf -0.112 1.0000
Sequence1 - Sequence8 127.79 213 Inf 0.601 0.9989
Sequence2 - Sequence3 -6.55 213 Inf -0.031 1.0000
Sequence2 - Sequence4 -235.04 213 Inf -1.106 0.9557
Sequence2 - Sequence5 -491.92 213 Inf -2.315 0.2853
Sequence2 - Sequence6 19.90 213 Inf 0.094 1.0000
Sequence2 - Sequence7 -120.54 190 Inf -0.634 0.9984
Sequence2 - Sequence8 28.52 213 Inf 0.134 1.0000
Sequence3 - Sequence4 -228.49 233 Inf -0.982 0.9771
Sequence3 - Sequence5 -485.37 233 Inf -2.085 0.4246
Sequence3 - Sequence6 26.45 233 Inf 0.114 1.0000
Sequence3 - Sequence7 -113.99 213 Inf -0.536 0.9995
Sequence3 - Sequence8 35.07 233 Inf 0.151 1.0000
Sequence4 - Sequence5 -256.88 233 Inf -1.103 0.9563
Sequence4 - Sequence6 254.94 233 Inf 1.095 0.9580
Sequence4 - Sequence7 114.50 213 Inf 0.539 0.9994
Sequence4 - Sequence8 263.57 233 Inf 1.132 0.9499
Sequence5 - Sequence6 511.82 233 Inf 2.199 0.3524
Sequence5 - Sequence7 371.38 213 Inf 1.748 0.6558
Sequence5 - Sequence8 520.45 233 Inf 2.236 0.3302
Sequence6 - Sequence7 -140.44 213 Inf -0.661 0.9979
Sequence6 - Sequence8 8.63 233 Inf 0.037 1.0000
Sequence7 - Sequence8 149.07 213 Inf 0.701 0.9970
Degrees-of-freedom method: asymptotic
P value adjustment: tukey method for comparing a family of 8 estimates
It seems like there is nos significant diffence in the RT between the various sequences
There is a spike in RT around the 13th sep. Could indicate concatenation but could also indicate the switch between 12 and 18
#Model to show which step has the higest RT
df_acc <- df_acc %>% mutate (sub.trial.number = as.factor (sub.trial.number))
M2 <- lmer (feedback.RT ~ 0 + sub.trial.number +
(1 | subject) + (1 | session) + (1 | trial) + (1 | corr_trials),
data = df_acc)
Warning in checkConv(attr(opt, "derivs"), opt$par, ctrl = control$checkConv, :
unable to evaluate scaled gradient
Warning in checkConv(attr(opt, "derivs"), opt$par, ctrl = control$checkConv, :
Model failed to converge: degenerate Hessian with 1 negative eigenvalues
Analysis of Deviance Table (Type II Wald chisquare tests)
Response: feedback.RT
Chisq Df Pr(>Chisq)
sub.trial.number 2051.9 18 < 2.2e-16 ***
---
Signif. codes: 0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1
ae.m.M2 <- allEffects (M2)
ae.m.M2.df <- as.data.frame (ae.m.M2[1 ])
plot (ae.m.M2)
Linear mixed model fit by REML ['lmerMod']
Formula: feedback.RT ~ 0 + sub.trial.number + (1 | subject) + (1 | session) +
(1 | trial) + (1 | corr_trials)
Data: df_acc
REML criterion at convergence: 283614.1
Scaled residuals:
Min 1Q Median 3Q Max
-4.192 -0.444 -0.154 0.223 34.702
Random effects:
Groups Name Variance Std.Dev.
trial (Intercept) 3059.4 55.31
corr_trials (Intercept) 14867.1 121.93
subject (Intercept) 31731.2 178.13
session (Intercept) 492.5 22.19
Residual 84337.2 290.41
Number of obs: 19992, groups:
trial, 48; corr_trials, 19; subject, 19; session, 3
Fixed effects:
Estimate Std. Error t value
sub.trial.number1 758.13 52.24 14.512
sub.trial.number2 462.98 52.24 8.862
sub.trial.number3 433.11 52.24 8.291
sub.trial.number4 429.20 52.24 8.216
sub.trial.number5 486.13 52.24 9.306
sub.trial.number6 469.19 52.24 8.981
sub.trial.number7 488.30 52.57 9.288
sub.trial.number8 466.01 52.57 8.864
sub.trial.number9 507.29 52.57 9.649
sub.trial.number10 492.82 52.57 9.374
sub.trial.number11 457.94 52.57 8.710
sub.trial.number12 430.47 52.57 8.188
sub.trial.number13 655.05 53.47 12.251
sub.trial.number14 529.92 53.47 9.911
sub.trial.number15 473.29 53.47 8.851
sub.trial.number16 408.08 53.47 7.632
sub.trial.number17 459.41 53.47 8.592
sub.trial.number18 447.91 53.47 8.377
Correlation matrix not shown by default, as p = 18 > 12.
Use print(x, correlation=TRUE) or
vcov(x) if you need it
optimizer (nloptwrap) convergence code: 0 (OK)
unable to evaluate scaled gradient
Model failed to converge: degenerate Hessian with 1 negative eigenvalues
posthoc <- emmeans (M2, ~ factor (sub.trial.number))
Note: D.f. calculations have been disabled because the number of observations exceeds 3000.
To enable adjustments, add the argument 'pbkrtest.limit = 19992' (or larger)
[or, globally, 'set emm_options(pbkrtest.limit = 19992)' or larger];
but be warned that this may result in large computation time and memory use.
Note: D.f. calculations have been disabled because the number of observations exceeds 3000.
To enable adjustments, add the argument 'lmerTest.limit = 19992' (or larger)
[or, globally, 'set emm_options(lmerTest.limit = 19992)' or larger];
but be warned that this may result in large computation time and memory use.
pairwise_comparisons <- pairs (posthoc)
summary (pairwise_comparisons)
contrast estimate SE df z.ratio p.value
sub.trial.number1 - sub.trial.number2 295.15 9.77 Inf 30.200 <.0001
sub.trial.number1 - sub.trial.number3 325.02 9.77 Inf 33.257 <.0001
sub.trial.number1 - sub.trial.number4 328.93 9.77 Inf 33.657 <.0001
sub.trial.number1 - sub.trial.number5 272.00 9.77 Inf 27.832 <.0001
sub.trial.number1 - sub.trial.number6 288.94 9.77 Inf 29.565 <.0001
sub.trial.number1 - sub.trial.number7 269.83 11.49 Inf 23.474 <.0001
sub.trial.number1 - sub.trial.number8 292.12 11.49 Inf 25.413 <.0001
sub.trial.number1 - sub.trial.number9 250.84 11.49 Inf 21.822 <.0001
sub.trial.number1 - sub.trial.number10 265.31 11.49 Inf 23.081 <.0001
sub.trial.number1 - sub.trial.number11 300.19 11.49 Inf 26.115 <.0001
sub.trial.number1 - sub.trial.number12 327.66 11.49 Inf 28.505 <.0001
sub.trial.number1 - sub.trial.number13 103.08 15.09 Inf 6.832 <.0001
sub.trial.number1 - sub.trial.number14 228.21 15.09 Inf 15.126 <.0001
sub.trial.number1 - sub.trial.number15 284.85 15.09 Inf 18.880 <.0001
sub.trial.number1 - sub.trial.number16 350.05 15.09 Inf 23.202 <.0001
sub.trial.number1 - sub.trial.number17 298.72 15.09 Inf 19.800 <.0001
sub.trial.number1 - sub.trial.number18 310.22 15.09 Inf 20.562 <.0001
sub.trial.number2 - sub.trial.number3 29.87 9.77 Inf 3.057 0.1737
sub.trial.number2 - sub.trial.number4 33.79 9.77 Inf 3.457 0.0553
sub.trial.number2 - sub.trial.number5 -23.15 9.77 Inf -2.369 0.6321
sub.trial.number2 - sub.trial.number6 -6.21 9.77 Inf -0.635 1.0000
sub.trial.number2 - sub.trial.number7 -25.32 11.49 Inf -2.203 0.7522
sub.trial.number2 - sub.trial.number8 -3.03 11.49 Inf -0.263 1.0000
sub.trial.number2 - sub.trial.number9 -44.30 11.49 Inf -3.854 0.0139
sub.trial.number2 - sub.trial.number10 -29.84 11.49 Inf -2.596 0.4566
sub.trial.number2 - sub.trial.number11 5.04 11.49 Inf 0.438 1.0000
sub.trial.number2 - sub.trial.number12 32.51 11.49 Inf 2.829 0.2946
sub.trial.number2 - sub.trial.number13 -192.07 15.09 Inf -12.731 <.0001
sub.trial.number2 - sub.trial.number14 -66.94 15.09 Inf -4.437 0.0013
sub.trial.number2 - sub.trial.number15 -10.30 15.09 Inf -0.683 1.0000
sub.trial.number2 - sub.trial.number16 54.90 15.09 Inf 3.639 0.0303
sub.trial.number2 - sub.trial.number17 3.57 15.09 Inf 0.237 1.0000
sub.trial.number2 - sub.trial.number18 15.07 15.09 Inf 0.999 0.9999
sub.trial.number3 - sub.trial.number4 3.91 9.77 Inf 0.400 1.0000
sub.trial.number3 - sub.trial.number5 -53.02 9.77 Inf -5.425 <.0001
sub.trial.number3 - sub.trial.number6 -36.08 9.77 Inf -3.692 0.0252
sub.trial.number3 - sub.trial.number7 -55.19 11.49 Inf -4.801 0.0002
sub.trial.number3 - sub.trial.number8 -32.90 11.49 Inf -2.862 0.2743
sub.trial.number3 - sub.trial.number9 -74.18 11.49 Inf -6.453 <.0001
sub.trial.number3 - sub.trial.number10 -59.71 11.49 Inf -5.195 <.0001
sub.trial.number3 - sub.trial.number11 -24.83 11.49 Inf -2.160 0.7800
sub.trial.number3 - sub.trial.number12 2.64 11.49 Inf 0.230 1.0000
sub.trial.number3 - sub.trial.number13 -221.94 15.09 Inf -14.711 <.0001
sub.trial.number3 - sub.trial.number14 -96.81 15.09 Inf -6.417 <.0001
sub.trial.number3 - sub.trial.number15 -40.17 15.09 Inf -2.663 0.4068
sub.trial.number3 - sub.trial.number16 25.03 15.09 Inf 1.659 0.9739
sub.trial.number3 - sub.trial.number17 -26.30 15.09 Inf -1.743 0.9583
sub.trial.number3 - sub.trial.number18 -14.80 15.09 Inf -0.981 1.0000
sub.trial.number4 - sub.trial.number5 -56.93 9.77 Inf -5.826 <.0001
sub.trial.number4 - sub.trial.number6 -39.99 9.77 Inf -4.092 0.0055
sub.trial.number4 - sub.trial.number7 -59.11 11.49 Inf -5.142 <.0001
sub.trial.number4 - sub.trial.number8 -36.81 11.49 Inf -3.202 0.1181
sub.trial.number4 - sub.trial.number9 -78.09 11.49 Inf -6.793 <.0001
sub.trial.number4 - sub.trial.number10 -63.62 11.49 Inf -5.535 <.0001
sub.trial.number4 - sub.trial.number11 -28.75 11.49 Inf -2.501 0.5296
sub.trial.number4 - sub.trial.number12 -1.27 11.49 Inf -0.111 1.0000
sub.trial.number4 - sub.trial.number13 -225.85 15.09 Inf -14.970 <.0001
sub.trial.number4 - sub.trial.number14 -100.72 15.09 Inf -6.676 <.0001
sub.trial.number4 - sub.trial.number15 -44.09 15.09 Inf -2.922 0.2399
sub.trial.number4 - sub.trial.number16 21.12 15.09 Inf 1.400 0.9958
sub.trial.number4 - sub.trial.number17 -30.21 15.09 Inf -2.003 0.8686
sub.trial.number4 - sub.trial.number18 -18.71 15.09 Inf -1.240 0.9990
sub.trial.number5 - sub.trial.number6 16.94 9.77 Inf 1.734 0.9603
sub.trial.number5 - sub.trial.number7 -2.17 11.49 Inf -0.189 1.0000
sub.trial.number5 - sub.trial.number8 20.12 11.49 Inf 1.751 0.9566
sub.trial.number5 - sub.trial.number9 -21.16 11.49 Inf -1.840 0.9326
sub.trial.number5 - sub.trial.number10 -6.69 11.49 Inf -0.582 1.0000
sub.trial.number5 - sub.trial.number11 28.19 11.49 Inf 2.452 0.5675
sub.trial.number5 - sub.trial.number12 55.66 11.49 Inf 4.842 0.0002
sub.trial.number5 - sub.trial.number13 -168.92 15.09 Inf -11.196 <.0001
sub.trial.number5 - sub.trial.number14 -43.79 15.09 Inf -2.903 0.2509
sub.trial.number5 - sub.trial.number15 12.85 15.09 Inf 0.851 1.0000
sub.trial.number5 - sub.trial.number16 78.05 15.09 Inf 5.173 <.0001
sub.trial.number5 - sub.trial.number17 26.72 15.09 Inf 1.771 0.9518
sub.trial.number5 - sub.trial.number18 38.22 15.09 Inf 2.533 0.5044
sub.trial.number6 - sub.trial.number7 -19.11 11.49 Inf -1.663 0.9733
sub.trial.number6 - sub.trial.number8 3.18 11.49 Inf 0.277 1.0000
sub.trial.number6 - sub.trial.number9 -38.10 11.49 Inf -3.314 0.0857
sub.trial.number6 - sub.trial.number10 -23.63 11.49 Inf -2.056 0.8414
sub.trial.number6 - sub.trial.number11 11.24 11.49 Inf 0.978 1.0000
sub.trial.number6 - sub.trial.number12 38.72 11.49 Inf 3.368 0.0729
sub.trial.number6 - sub.trial.number13 -185.86 15.09 Inf -12.319 <.0001
sub.trial.number6 - sub.trial.number14 -60.73 15.09 Inf -4.026 0.0072
sub.trial.number6 - sub.trial.number15 -4.10 15.09 Inf -0.272 1.0000
sub.trial.number6 - sub.trial.number16 61.11 15.09 Inf 4.050 0.0065
sub.trial.number6 - sub.trial.number17 9.78 15.09 Inf 0.648 1.0000
sub.trial.number6 - sub.trial.number18 21.28 15.09 Inf 1.410 0.9954
sub.trial.number7 - sub.trial.number8 22.29 12.60 Inf 1.770 0.9521
sub.trial.number7 - sub.trial.number9 -18.98 12.60 Inf -1.507 0.9903
sub.trial.number7 - sub.trial.number10 -4.52 12.60 Inf -0.359 1.0000
sub.trial.number7 - sub.trial.number11 30.36 12.60 Inf 2.410 0.6001
sub.trial.number7 - sub.trial.number12 57.83 12.60 Inf 4.591 0.0006
sub.trial.number7 - sub.trial.number13 -166.75 15.94 Inf -10.459 <.0001
sub.trial.number7 - sub.trial.number14 -41.62 15.94 Inf -2.610 0.4455
sub.trial.number7 - sub.trial.number15 15.02 15.94 Inf 0.942 1.0000
sub.trial.number7 - sub.trial.number16 80.22 15.94 Inf 5.032 0.0001
sub.trial.number7 - sub.trial.number17 28.89 15.94 Inf 1.812 0.9410
sub.trial.number7 - sub.trial.number18 40.39 15.94 Inf 2.534 0.5042
sub.trial.number8 - sub.trial.number9 -41.28 12.60 Inf -3.277 0.0956
sub.trial.number8 - sub.trial.number10 -26.81 12.60 Inf -2.129 0.7998
sub.trial.number8 - sub.trial.number11 8.06 12.60 Inf 0.640 1.0000
sub.trial.number8 - sub.trial.number12 35.54 12.60 Inf 2.821 0.2991
sub.trial.number8 - sub.trial.number13 -189.04 15.94 Inf -11.858 <.0001
sub.trial.number8 - sub.trial.number14 -63.91 15.94 Inf -4.009 0.0077
sub.trial.number8 - sub.trial.number15 -7.28 15.94 Inf -0.456 1.0000
sub.trial.number8 - sub.trial.number16 57.93 15.94 Inf 3.634 0.0308
sub.trial.number8 - sub.trial.number17 6.60 15.94 Inf 0.414 1.0000
sub.trial.number8 - sub.trial.number18 18.10 15.94 Inf 1.135 0.9997
sub.trial.number9 - sub.trial.number10 14.47 12.60 Inf 1.148 0.9996
sub.trial.number9 - sub.trial.number11 49.34 12.60 Inf 3.917 0.0110
sub.trial.number9 - sub.trial.number12 76.82 12.60 Inf 6.098 <.0001
sub.trial.number9 - sub.trial.number13 -147.77 15.94 Inf -9.268 <.0001
sub.trial.number9 - sub.trial.number14 -22.63 15.94 Inf -1.420 0.9950
sub.trial.number9 - sub.trial.number15 34.00 15.94 Inf 2.133 0.7972
sub.trial.number9 - sub.trial.number16 99.21 15.94 Inf 6.223 <.0001
sub.trial.number9 - sub.trial.number17 47.88 15.94 Inf 3.003 0.1984
sub.trial.number9 - sub.trial.number18 59.38 15.94 Inf 3.724 0.0224
sub.trial.number10 - sub.trial.number11 34.88 12.60 Inf 2.769 0.3330
sub.trial.number10 - sub.trial.number12 62.35 12.60 Inf 4.950 0.0001
sub.trial.number10 - sub.trial.number13 -162.23 15.94 Inf -10.176 <.0001
sub.trial.number10 - sub.trial.number14 -37.10 15.94 Inf -2.327 0.6635
sub.trial.number10 - sub.trial.number15 19.54 15.94 Inf 1.225 0.9992
sub.trial.number10 - sub.trial.number16 84.74 15.94 Inf 5.315 <.0001
sub.trial.number10 - sub.trial.number17 33.41 15.94 Inf 2.096 0.8193
sub.trial.number10 - sub.trial.number18 44.91 15.94 Inf 2.817 0.3019
sub.trial.number11 - sub.trial.number12 27.47 12.60 Inf 2.181 0.7666
sub.trial.number11 - sub.trial.number13 -197.11 15.94 Inf -12.363 <.0001
sub.trial.number11 - sub.trial.number14 -71.98 15.94 Inf -4.515 0.0009
sub.trial.number11 - sub.trial.number15 -15.34 15.94 Inf -0.962 1.0000
sub.trial.number11 - sub.trial.number16 49.86 15.94 Inf 3.128 0.1446
sub.trial.number11 - sub.trial.number17 -1.47 15.94 Inf -0.092 1.0000
sub.trial.number11 - sub.trial.number18 10.03 15.94 Inf 0.629 1.0000
sub.trial.number12 - sub.trial.number13 -224.58 15.94 Inf -14.087 <.0001
sub.trial.number12 - sub.trial.number14 -99.45 15.94 Inf -6.238 <.0001
sub.trial.number12 - sub.trial.number15 -42.82 15.94 Inf -2.686 0.3904
sub.trial.number12 - sub.trial.number16 22.39 15.94 Inf 1.404 0.9956
sub.trial.number12 - sub.trial.number17 -28.94 15.94 Inf -1.815 0.9401
sub.trial.number12 - sub.trial.number18 -17.44 15.94 Inf -1.094 0.9998
sub.trial.number13 - sub.trial.number14 125.13 18.31 Inf 6.833 <.0001
sub.trial.number13 - sub.trial.number15 181.77 18.31 Inf 9.926 <.0001
sub.trial.number13 - sub.trial.number16 246.97 18.31 Inf 13.487 <.0001
sub.trial.number13 - sub.trial.number17 195.64 18.31 Inf 10.684 <.0001
sub.trial.number13 - sub.trial.number18 207.14 18.31 Inf 11.312 <.0001
sub.trial.number14 - sub.trial.number15 56.64 18.31 Inf 3.093 0.1584
sub.trial.number14 - sub.trial.number16 121.84 18.31 Inf 6.654 <.0001
sub.trial.number14 - sub.trial.number17 70.51 18.31 Inf 3.850 0.0141
sub.trial.number14 - sub.trial.number18 82.01 18.31 Inf 4.478 0.0010
sub.trial.number15 - sub.trial.number16 65.20 18.31 Inf 3.561 0.0395
sub.trial.number15 - sub.trial.number17 13.87 18.31 Inf 0.758 1.0000
sub.trial.number15 - sub.trial.number18 25.37 18.31 Inf 1.386 0.9962
sub.trial.number16 - sub.trial.number17 -51.33 18.31 Inf -2.803 0.3107
sub.trial.number16 - sub.trial.number18 -39.83 18.31 Inf -2.175 0.7705
sub.trial.number17 - sub.trial.number18 11.50 18.31 Inf 0.628 1.0000
Degrees-of-freedom method: asymptotic
P value adjustment: tukey method for comparing a family of 18 estimates
#Plot by block
df_B1 <- df_acc %>% filter (session == 1 )
df_B2 <- df_acc %>% filter (session == 2 )
df_B3 <- df_acc %>% filter (session == 3 )
#Block 1
M_B1 <- lmer (feedback.RT ~ 0 + sub.trial.number +
(1 | subject) + (1 | trial)+ (1 | corr_trials),
data = df_B1)
Anova (M_B1)
Analysis of Deviance Table (Type II Wald chisquare tests)
Response: feedback.RT
Chisq Df Pr(>Chisq)
sub.trial.number 667.36 6 < 2.2e-16 ***
---
Signif. codes: 0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1
ae.m.M_B1 <- allEffects (M_B1)
ae.m.M_B1.df <- as.data.frame (ae.m.M_B1[1 ])
plot (ae.m.M_B1)
Linear mixed model fit by REML ['lmerMod']
Formula: feedback.RT ~ 0 + sub.trial.number + (1 | subject) + (1 | trial) +
(1 | corr_trials)
Data: df_B1
REML criterion at convergence: 60410.4
Scaled residuals:
Min 1Q Median 3Q Max
-4.4627 -0.3631 -0.0794 0.2521 30.8225
Random effects:
Groups Name Variance Std.Dev.
trial (Intercept) 15377.3 124.01
corr_trials (Intercept) 157.6 12.55
subject (Intercept) 70149.6 264.86
Residual 93340.4 305.52
Number of obs: 4218, groups: trial, 48; corr_trials, 18; subject, 18
Fixed effects:
Estimate Std. Error t value
sub.trial.number1 765.80 66.03 11.597
sub.trial.number2 464.10 66.03 7.028
sub.trial.number3 443.18 66.03 6.712
sub.trial.number4 455.04 66.03 6.891
sub.trial.number5 463.85 66.03 7.025
sub.trial.number6 451.13 66.03 6.832
Correlation of Fixed Effects:
sb.t.1 sb.t.2 sb.t.3 sb.t.4 sb.t.5
sb.trl.nmb2 0.970
sb.trl.nmb3 0.970 0.970
sb.trl.nmb4 0.970 0.970 0.970
sb.trl.nmb5 0.970 0.970 0.970 0.970
sb.trl.nmb6 0.970 0.970 0.970 0.970 0.970
posthocM_B1 <- emmeans (M_B1, ~ factor (sub.trial.number))
Note: D.f. calculations have been disabled because the number of observations exceeds 3000.
To enable adjustments, add the argument 'pbkrtest.limit = 4218' (or larger)
[or, globally, 'set emm_options(pbkrtest.limit = 4218)' or larger];
but be warned that this may result in large computation time and memory use.
Note: D.f. calculations have been disabled because the number of observations exceeds 3000.
To enable adjustments, add the argument 'lmerTest.limit = 4218' (or larger)
[or, globally, 'set emm_options(lmerTest.limit = 4218)' or larger];
but be warned that this may result in large computation time and memory use.
pairwise_comparisonsM_B1 <- pairs (posthocM_B1)
summary (pairwise_comparisonsM_B1)
contrast estimate SE df z.ratio p.value
sub.trial.number1 - sub.trial.number2 301.691 16.3 Inf 18.514 <.0001
sub.trial.number1 - sub.trial.number3 322.613 16.3 Inf 19.797 <.0001
sub.trial.number1 - sub.trial.number4 310.754 16.3 Inf 19.070 <.0001
sub.trial.number1 - sub.trial.number5 301.947 16.3 Inf 18.529 <.0001
sub.trial.number1 - sub.trial.number6 314.669 16.3 Inf 19.310 <.0001
sub.trial.number2 - sub.trial.number3 20.922 16.3 Inf 1.284 0.7940
sub.trial.number2 - sub.trial.number4 9.063 16.3 Inf 0.556 0.9937
sub.trial.number2 - sub.trial.number5 0.256 16.3 Inf 0.016 1.0000
sub.trial.number2 - sub.trial.number6 12.977 16.3 Inf 0.796 0.9682
sub.trial.number3 - sub.trial.number4 -11.859 16.3 Inf -0.728 0.9786
sub.trial.number3 - sub.trial.number5 -20.666 16.3 Inf -1.268 0.8025
sub.trial.number3 - sub.trial.number6 -7.944 16.3 Inf -0.488 0.9966
sub.trial.number4 - sub.trial.number5 -8.806 16.3 Inf -0.540 0.9945
sub.trial.number4 - sub.trial.number6 3.915 16.3 Inf 0.240 0.9999
sub.trial.number5 - sub.trial.number6 12.721 16.3 Inf 0.781 0.9709
Degrees-of-freedom method: asymptotic
P value adjustment: tukey method for comparing a family of 6 estimates
#Block 2
M_B2 <- lmer (feedback.RT ~ 0 + sub.trial.number +
(1 | subject) + (1 | trial)+ (1 | corr_trials),
data = df_B2)
Anova (M_B2)
Analysis of Deviance Table (Type II Wald chisquare tests)
Response: feedback.RT
Chisq Df Pr(>Chisq)
sub.trial.number 888.87 12 < 2.2e-16 ***
---
Signif. codes: 0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1
ae.m.M_B2 <- allEffects (M_B2)
ae.m.M_B2.df <- as.data.frame (ae.m.M_B2[1 ])
plot (ae.m.M_B2)
Linear mixed model fit by REML ['lmerMod']
Formula: feedback.RT ~ 0 + sub.trial.number + (1 | subject) + (1 | trial) +
(1 | corr_trials)
Data: df_B2
REML criterion at convergence: 92763.4
Scaled residuals:
Min 1Q Median 3Q Max
-4.1985 -0.4772 -0.1781 0.2289 13.3500
Random effects:
Groups Name Variance Std.Dev.
trial (Intercept) 1775 42.13
corr_trials (Intercept) 41136 202.82
subject (Intercept) 18256 135.11
Residual 57128 239.01
Number of obs: 6720, groups: trial, 48; corr_trials, 18; subject, 18
Fixed effects:
Estimate Std. Error t value
sub.trial.number1 745.29 58.65 12.707
sub.trial.number2 469.58 58.65 8.006
sub.trial.number3 438.43 58.65 7.475
sub.trial.number4 413.46 58.65 7.049
sub.trial.number5 516.31 58.65 8.803
sub.trial.number6 479.33 58.65 8.172
sub.trial.number7 506.57 58.65 8.637
sub.trial.number8 483.33 58.65 8.241
sub.trial.number9 509.96 58.65 8.695
sub.trial.number10 470.30 58.65 8.019
sub.trial.number11 436.94 58.65 7.450
sub.trial.number12 422.89 58.65 7.210
Correlation of Fixed Effects:
sb.t.1 sb.t.2 sb.t.3 sb.t.4 sb.t.5 sb.t.6 sb.t.7 sb.t.8 sb.t.9
sb.trl.nmb2 0.970
sb.trl.nmb3 0.970 0.970
sb.trl.nmb4 0.970 0.970 0.970
sb.trl.nmb5 0.970 0.970 0.970 0.970
sb.trl.nmb6 0.970 0.970 0.970 0.970 0.970
sb.trl.nmb7 0.970 0.970 0.970 0.970 0.970 0.970
sb.trl.nmb8 0.970 0.970 0.970 0.970 0.970 0.970 0.970
sb.trl.nmb9 0.970 0.970 0.970 0.970 0.970 0.970 0.970 0.970
sb.trl.nm10 0.970 0.970 0.970 0.970 0.970 0.970 0.970 0.970 0.970
sb.trl.nm11 0.970 0.970 0.970 0.970 0.970 0.970 0.970 0.970 0.970
sb.trl.nm12 0.970 0.970 0.970 0.970 0.970 0.970 0.970 0.970 0.970
sb..10 sb..11
sb.trl.nmb2
sb.trl.nmb3
sb.trl.nmb4
sb.trl.nmb5
sb.trl.nmb6
sb.trl.nmb7
sb.trl.nmb8
sb.trl.nmb9
sb.trl.nm10
sb.trl.nm11 0.970
sb.trl.nm12 0.970 0.970
posthocM_B2 <- emmeans (M_B2, ~ factor (sub.trial.number))
Note: D.f. calculations have been disabled because the number of observations exceeds 3000.
To enable adjustments, add the argument 'pbkrtest.limit = 6720' (or larger)
[or, globally, 'set emm_options(pbkrtest.limit = 6720)' or larger];
but be warned that this may result in large computation time and memory use.
Note: D.f. calculations have been disabled because the number of observations exceeds 3000.
To enable adjustments, add the argument 'lmerTest.limit = 6720' (or larger)
[or, globally, 'set emm_options(lmerTest.limit = 6720)' or larger];
but be warned that this may result in large computation time and memory use.
pairwise_comparisonsM_B2 <- pairs (posthocM_B2)
summary (pairwise_comparisonsM_B2)
contrast estimate SE df z.ratio p.value
sub.trial.number1 - sub.trial.number2 275.707 14.3 Inf 19.302 <.0001
sub.trial.number1 - sub.trial.number3 306.861 14.3 Inf 21.483 <.0001
sub.trial.number1 - sub.trial.number4 331.834 14.3 Inf 23.231 <.0001
sub.trial.number1 - sub.trial.number5 228.984 14.3 Inf 16.031 <.0001
sub.trial.number1 - sub.trial.number6 265.964 14.3 Inf 18.620 <.0001
sub.trial.number1 - sub.trial.number7 238.716 14.3 Inf 16.712 <.0001
sub.trial.number1 - sub.trial.number8 261.957 14.3 Inf 18.339 <.0001
sub.trial.number1 - sub.trial.number9 235.332 14.3 Inf 16.475 <.0001
sub.trial.number1 - sub.trial.number10 274.986 14.3 Inf 19.251 <.0001
sub.trial.number1 - sub.trial.number11 308.355 14.3 Inf 21.588 <.0001
sub.trial.number1 - sub.trial.number12 322.405 14.3 Inf 22.571 <.0001
sub.trial.number2 - sub.trial.number3 31.154 14.3 Inf 2.181 0.5635
sub.trial.number2 - sub.trial.number4 56.127 14.3 Inf 3.929 0.0049
sub.trial.number2 - sub.trial.number5 -46.723 14.3 Inf -3.271 0.0495
sub.trial.number2 - sub.trial.number6 -9.743 14.3 Inf -0.682 0.9999
sub.trial.number2 - sub.trial.number7 -36.991 14.3 Inf -2.590 0.2853
sub.trial.number2 - sub.trial.number8 -13.750 14.3 Inf -0.963 0.9984
sub.trial.number2 - sub.trial.number9 -40.375 14.3 Inf -2.827 0.1687
sub.trial.number2 - sub.trial.number10 -0.721 14.3 Inf -0.051 1.0000
sub.trial.number2 - sub.trial.number11 32.648 14.3 Inf 2.286 0.4868
sub.trial.number2 - sub.trial.number12 46.698 14.3 Inf 3.269 0.0498
sub.trial.number3 - sub.trial.number4 24.973 14.3 Inf 1.748 0.8456
sub.trial.number3 - sub.trial.number5 -77.877 14.3 Inf -5.452 <.0001
sub.trial.number3 - sub.trial.number6 -40.896 14.3 Inf -2.863 0.1543
sub.trial.number3 - sub.trial.number7 -68.145 14.3 Inf -4.771 0.0001
sub.trial.number3 - sub.trial.number8 -44.904 14.3 Inf -3.144 0.0725
sub.trial.number3 - sub.trial.number9 -71.529 14.3 Inf -5.008 <.0001
sub.trial.number3 - sub.trial.number10 -31.875 14.3 Inf -2.232 0.5264
sub.trial.number3 - sub.trial.number11 1.495 14.3 Inf 0.105 1.0000
sub.trial.number3 - sub.trial.number12 15.545 14.3 Inf 1.088 0.9952
sub.trial.number4 - sub.trial.number5 -102.850 14.3 Inf -7.200 <.0001
sub.trial.number4 - sub.trial.number6 -65.870 14.3 Inf -4.611 0.0003
sub.trial.number4 - sub.trial.number7 -93.118 14.3 Inf -6.519 <.0001
sub.trial.number4 - sub.trial.number8 -69.877 14.3 Inf -4.892 0.0001
sub.trial.number4 - sub.trial.number9 -96.502 14.3 Inf -6.756 <.0001
sub.trial.number4 - sub.trial.number10 -56.848 14.3 Inf -3.980 0.0040
sub.trial.number4 - sub.trial.number11 -23.479 14.3 Inf -1.644 0.8929
sub.trial.number4 - sub.trial.number12 -9.429 14.3 Inf -0.660 1.0000
sub.trial.number5 - sub.trial.number6 36.980 14.3 Inf 2.589 0.2858
sub.trial.number5 - sub.trial.number7 9.732 14.3 Inf 0.681 0.9999
sub.trial.number5 - sub.trial.number8 32.973 14.3 Inf 2.308 0.4704
sub.trial.number5 - sub.trial.number9 6.348 14.3 Inf 0.444 1.0000
sub.trial.number5 - sub.trial.number10 46.002 14.3 Inf 3.221 0.0578
sub.trial.number5 - sub.trial.number11 79.371 14.3 Inf 5.557 <.0001
sub.trial.number5 - sub.trial.number12 93.421 14.3 Inf 6.540 <.0001
sub.trial.number6 - sub.trial.number7 -27.248 14.3 Inf -1.908 0.7548
sub.trial.number6 - sub.trial.number8 -4.007 14.3 Inf -0.281 1.0000
sub.trial.number6 - sub.trial.number9 -30.632 14.3 Inf -2.145 0.5904
sub.trial.number6 - sub.trial.number10 9.021 14.3 Inf 0.632 1.0000
sub.trial.number6 - sub.trial.number11 42.391 14.3 Inf 2.968 0.1181
sub.trial.number6 - sub.trial.number12 56.441 14.3 Inf 3.951 0.0044
sub.trial.number7 - sub.trial.number8 23.241 14.3 Inf 1.627 0.8995
sub.trial.number7 - sub.trial.number9 -3.384 14.3 Inf -0.237 1.0000
sub.trial.number7 - sub.trial.number10 36.270 14.3 Inf 2.539 0.3153
sub.trial.number7 - sub.trial.number11 69.639 14.3 Inf 4.875 0.0001
sub.trial.number7 - sub.trial.number12 83.689 14.3 Inf 5.859 <.0001
sub.trial.number8 - sub.trial.number9 -26.625 14.3 Inf -1.864 0.7817
sub.trial.number8 - sub.trial.number10 13.029 14.3 Inf 0.912 0.9990
sub.trial.number8 - sub.trial.number11 46.398 14.3 Inf 3.248 0.0531
sub.trial.number8 - sub.trial.number12 60.448 14.3 Inf 4.232 0.0014
sub.trial.number9 - sub.trial.number10 39.654 14.3 Inf 2.776 0.1901
sub.trial.number9 - sub.trial.number11 73.023 14.3 Inf 5.112 <.0001
sub.trial.number9 - sub.trial.number12 87.073 14.3 Inf 6.096 <.0001
sub.trial.number10 - sub.trial.number11 33.370 14.3 Inf 2.336 0.4505
sub.trial.number10 - sub.trial.number12 47.420 14.3 Inf 3.320 0.0425
sub.trial.number11 - sub.trial.number12 14.050 14.3 Inf 0.984 0.9980
Degrees-of-freedom method: asymptotic
P value adjustment: tukey method for comparing a family of 12 estimates
#Block 3
M_B3 <- lmer (feedback.RT ~ 0 + sub.trial.number +
(1 | subject) + (1 | trial)+ (1 | corr_trials),
data = df_B3)
Warning in checkConv(attr(opt, "derivs"), opt$par, ctrl = control$checkConv, :
unable to evaluate scaled gradient
Warning in checkConv(attr(opt, "derivs"), opt$par, ctrl = control$checkConv, :
Model failed to converge: degenerate Hessian with 1 negative eigenvalues
Analysis of Deviance Table (Type II Wald chisquare tests)
Response: feedback.RT
Chisq Df Pr(>Chisq)
sub.trial.number 877.71 18 < 2.2e-16 ***
---
Signif. codes: 0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1
ae.m.M_B3 <- allEffects (M_B3)
ae.m.M_B3.df <- as.data.frame (ae.m.M_B3[1 ])
plot (ae.m.M_B3)
Linear mixed model fit by REML ['lmerMod']
Formula: feedback.RT ~ 0 + sub.trial.number + (1 | subject) + (1 | trial) +
(1 | corr_trials)
Data: df_B3
REML criterion at convergence: 128810.3
Scaled residuals:
Min 1Q Median 3Q Max
-2.595 -0.431 -0.160 0.193 34.000
Random effects:
Groups Name Variance Std.Dev.
trial (Intercept) 1613.8 40.17
corr_trials (Intercept) 260.8 16.15
subject (Intercept) 40765.9 201.91
Residual 88154.4 296.91
Number of obs: 9054, groups: trial, 47; corr_trials, 19; subject, 19
Fixed effects:
Estimate Std. Error t value
sub.trial.number1 794.8 48.7 16.319
sub.trial.number2 487.2 48.7 10.002
sub.trial.number3 446.2 48.7 9.162
sub.trial.number4 443.7 48.7 9.110
sub.trial.number5 516.8 48.7 10.610
sub.trial.number6 516.2 48.7 10.599
sub.trial.number7 499.2 48.7 10.249
sub.trial.number8 477.9 48.7 9.813
sub.trial.number9 535.5 48.7 10.996
sub.trial.number10 549.1 48.7 11.274
sub.trial.number11 512.5 48.7 10.524
sub.trial.number12 470.1 48.7 9.653
sub.trial.number13 685.0 48.7 14.064
sub.trial.number14 559.9 48.7 11.495
sub.trial.number15 503.2 48.7 10.332
sub.trial.number16 438.0 48.7 8.993
sub.trial.number17 489.4 48.7 10.047
sub.trial.number18 477.9 48.7 9.811
Correlation matrix not shown by default, as p = 18 > 12.
Use print(x, correlation=TRUE) or
vcov(x) if you need it
optimizer (nloptwrap) convergence code: 0 (OK)
unable to evaluate scaled gradient
Model failed to converge: degenerate Hessian with 1 negative eigenvalues
posthocM_B3 <- emmeans (M_B3, ~ factor (sub.trial.number))
Note: D.f. calculations have been disabled because the number of observations exceeds 3000.
To enable adjustments, add the argument 'pbkrtest.limit = 9054' (or larger)
[or, globally, 'set emm_options(pbkrtest.limit = 9054)' or larger];
but be warned that this may result in large computation time and memory use.
Note: D.f. calculations have been disabled because the number of observations exceeds 3000.
To enable adjustments, add the argument 'lmerTest.limit = 9054' (or larger)
[or, globally, 'set emm_options(lmerTest.limit = 9054)' or larger];
but be warned that this may result in large computation time and memory use.
pairwise_comparisonsM_B3 <- pairs (posthocM_B3)
summary (pairwise_comparisonsM_B3)
contrast estimate SE df z.ratio p.value
sub.trial.number1 - sub.trial.number2 307.6481 18.7 Inf 16.432 <.0001
sub.trial.number1 - sub.trial.number3 348.6044 18.7 Inf 18.620 <.0001
sub.trial.number1 - sub.trial.number4 351.1133 18.7 Inf 18.754 <.0001
sub.trial.number1 - sub.trial.number5 278.0378 18.7 Inf 14.851 <.0001
sub.trial.number1 - sub.trial.number6 278.5726 18.7 Inf 14.879 <.0001
sub.trial.number1 - sub.trial.number7 295.6322 18.7 Inf 15.791 <.0001
sub.trial.number1 - sub.trial.number8 316.8728 18.7 Inf 16.925 <.0001
sub.trial.number1 - sub.trial.number9 259.2803 18.7 Inf 13.849 <.0001
sub.trial.number1 - sub.trial.number10 245.7038 18.7 Inf 13.124 <.0001
sub.trial.number1 - sub.trial.number11 282.2604 18.7 Inf 15.076 <.0001
sub.trial.number1 - sub.trial.number12 324.6799 18.7 Inf 17.342 <.0001
sub.trial.number1 - sub.trial.number13 109.8211 18.7 Inf 5.866 <.0001
sub.trial.number1 - sub.trial.number14 234.9523 18.7 Inf 12.550 <.0001
sub.trial.number1 - sub.trial.number15 291.5885 18.7 Inf 15.575 <.0001
sub.trial.number1 - sub.trial.number16 356.7932 18.7 Inf 19.057 <.0001
sub.trial.number1 - sub.trial.number17 305.4632 18.7 Inf 16.316 <.0001
sub.trial.number1 - sub.trial.number18 316.9622 18.7 Inf 16.930 <.0001
sub.trial.number2 - sub.trial.number3 40.9563 18.7 Inf 2.188 0.7623
sub.trial.number2 - sub.trial.number4 43.4652 18.7 Inf 2.322 0.6675
sub.trial.number2 - sub.trial.number5 -29.6103 18.7 Inf -1.582 0.9839
sub.trial.number2 - sub.trial.number6 -29.0755 18.7 Inf -1.553 0.9866
sub.trial.number2 - sub.trial.number7 -12.0159 18.7 Inf -0.642 1.0000
sub.trial.number2 - sub.trial.number8 9.2247 18.7 Inf 0.493 1.0000
sub.trial.number2 - sub.trial.number9 -48.3678 18.7 Inf -2.583 0.4659
sub.trial.number2 - sub.trial.number10 -61.9443 18.7 Inf -3.309 0.0872
sub.trial.number2 - sub.trial.number11 -25.3877 18.7 Inf -1.356 0.9971
sub.trial.number2 - sub.trial.number12 17.0318 18.7 Inf 0.910 1.0000
sub.trial.number2 - sub.trial.number13 -197.8270 18.7 Inf -10.567 <.0001
sub.trial.number2 - sub.trial.number14 -72.6958 18.7 Inf -3.883 0.0125
sub.trial.number2 - sub.trial.number15 -16.0596 18.7 Inf -0.858 1.0000
sub.trial.number2 - sub.trial.number16 49.1451 18.7 Inf 2.625 0.4347
sub.trial.number2 - sub.trial.number17 -2.1849 18.7 Inf -0.117 1.0000
sub.trial.number2 - sub.trial.number18 9.3141 18.7 Inf 0.497 1.0000
sub.trial.number3 - sub.trial.number4 2.5089 18.7 Inf 0.134 1.0000
sub.trial.number3 - sub.trial.number5 -70.5666 18.7 Inf -3.769 0.0191
sub.trial.number3 - sub.trial.number6 -70.0318 18.7 Inf -3.741 0.0212
sub.trial.number3 - sub.trial.number7 -52.9722 18.7 Inf -2.829 0.2941
sub.trial.number3 - sub.trial.number8 -31.7316 18.7 Inf -1.695 0.9679
sub.trial.number3 - sub.trial.number9 -89.3241 18.7 Inf -4.771 0.0003
sub.trial.number3 - sub.trial.number10 -102.9006 18.7 Inf -5.496 <.0001
sub.trial.number3 - sub.trial.number11 -66.3439 18.7 Inf -3.544 0.0418
sub.trial.number3 - sub.trial.number12 -23.9245 18.7 Inf -1.278 0.9986
sub.trial.number3 - sub.trial.number13 -238.7833 18.7 Inf -12.754 <.0001
sub.trial.number3 - sub.trial.number14 -113.6521 18.7 Inf -6.070 <.0001
sub.trial.number3 - sub.trial.number15 -57.0159 18.7 Inf -3.045 0.1787
sub.trial.number3 - sub.trial.number16 8.1889 18.7 Inf 0.437 1.0000
sub.trial.number3 - sub.trial.number17 -43.1412 18.7 Inf -2.304 0.6804
sub.trial.number3 - sub.trial.number18 -31.6421 18.7 Inf -1.690 0.9688
sub.trial.number4 - sub.trial.number5 -73.0755 18.7 Inf -3.903 0.0116
sub.trial.number4 - sub.trial.number6 -72.5408 18.7 Inf -3.875 0.0129
sub.trial.number4 - sub.trial.number7 -55.4811 18.7 Inf -2.963 0.2181
sub.trial.number4 - sub.trial.number8 -34.2406 18.7 Inf -1.829 0.9361
sub.trial.number4 - sub.trial.number9 -91.8330 18.7 Inf -4.905 0.0001
sub.trial.number4 - sub.trial.number10 -105.4095 18.7 Inf -5.630 <.0001
sub.trial.number4 - sub.trial.number11 -68.8529 18.7 Inf -3.678 0.0265
sub.trial.number4 - sub.trial.number12 -26.4334 18.7 Inf -1.412 0.9953
sub.trial.number4 - sub.trial.number13 -241.2922 18.7 Inf -12.888 <.0001
sub.trial.number4 - sub.trial.number14 -116.1610 18.7 Inf -6.205 <.0001
sub.trial.number4 - sub.trial.number15 -59.5249 18.7 Inf -3.179 0.1258
sub.trial.number4 - sub.trial.number16 5.6799 18.7 Inf 0.303 1.0000
sub.trial.number4 - sub.trial.number17 -45.6501 18.7 Inf -2.438 0.5782
sub.trial.number4 - sub.trial.number18 -34.1511 18.7 Inf -1.824 0.9376
sub.trial.number5 - sub.trial.number6 0.5348 18.7 Inf 0.029 1.0000
sub.trial.number5 - sub.trial.number7 17.5944 18.7 Inf 0.940 1.0000
sub.trial.number5 - sub.trial.number8 38.8350 18.7 Inf 2.074 0.8314
sub.trial.number5 - sub.trial.number9 -18.7575 18.7 Inf -1.002 0.9999
sub.trial.number5 - sub.trial.number10 -32.3340 18.7 Inf -1.727 0.9617
sub.trial.number5 - sub.trial.number11 4.2227 18.7 Inf 0.226 1.0000
sub.trial.number5 - sub.trial.number12 46.6421 18.7 Inf 2.491 0.5370
sub.trial.number5 - sub.trial.number13 -168.2167 18.7 Inf -8.985 <.0001
sub.trial.number5 - sub.trial.number14 -43.0855 18.7 Inf -2.301 0.6826
sub.trial.number5 - sub.trial.number15 13.5507 18.7 Inf 0.724 1.0000
sub.trial.number5 - sub.trial.number16 78.7555 18.7 Inf 4.207 0.0034
sub.trial.number5 - sub.trial.number17 27.4254 18.7 Inf 1.465 0.9929
sub.trial.number5 - sub.trial.number18 38.9245 18.7 Inf 2.079 0.8287
sub.trial.number6 - sub.trial.number7 17.0596 18.7 Inf 0.911 1.0000
sub.trial.number6 - sub.trial.number8 38.3002 18.7 Inf 2.046 0.8468
sub.trial.number6 - sub.trial.number9 -19.2922 18.7 Inf -1.030 0.9999
sub.trial.number6 - sub.trial.number10 -32.8688 18.7 Inf -1.756 0.9555
sub.trial.number6 - sub.trial.number11 3.6879 18.7 Inf 0.197 1.0000
sub.trial.number6 - sub.trial.number12 46.1074 18.7 Inf 2.463 0.5592
sub.trial.number6 - sub.trial.number13 -168.7515 18.7 Inf -9.014 <.0001
sub.trial.number6 - sub.trial.number14 -43.6203 18.7 Inf -2.330 0.6614
sub.trial.number6 - sub.trial.number15 13.0159 18.7 Inf 0.695 1.0000
sub.trial.number6 - sub.trial.number16 78.2207 18.7 Inf 4.178 0.0039
sub.trial.number6 - sub.trial.number17 26.8907 18.7 Inf 1.436 0.9943
sub.trial.number6 - sub.trial.number18 38.3897 18.7 Inf 2.051 0.8443
sub.trial.number7 - sub.trial.number8 21.2406 18.7 Inf 1.135 0.9997
sub.trial.number7 - sub.trial.number9 -36.3519 18.7 Inf -1.942 0.8959
sub.trial.number7 - sub.trial.number10 -49.9284 18.7 Inf -2.667 0.4039
sub.trial.number7 - sub.trial.number11 -13.3718 18.7 Inf -0.714 1.0000
sub.trial.number7 - sub.trial.number12 29.0477 18.7 Inf 1.552 0.9868
sub.trial.number7 - sub.trial.number13 -185.8111 18.7 Inf -9.925 <.0001
sub.trial.number7 - sub.trial.number14 -60.6799 18.7 Inf -3.241 0.1060
sub.trial.number7 - sub.trial.number15 -4.0437 18.7 Inf -0.216 1.0000
sub.trial.number7 - sub.trial.number16 61.1610 18.7 Inf 3.267 0.0985
sub.trial.number7 - sub.trial.number17 9.8310 18.7 Inf 0.525 1.0000
sub.trial.number7 - sub.trial.number18 21.3300 18.7 Inf 1.139 0.9997
sub.trial.number8 - sub.trial.number9 -57.5924 18.7 Inf -3.076 0.1653
sub.trial.number8 - sub.trial.number10 -71.1690 18.7 Inf -3.801 0.0170
sub.trial.number8 - sub.trial.number11 -34.6123 18.7 Inf -1.849 0.9300
sub.trial.number8 - sub.trial.number12 7.8072 18.7 Inf 0.417 1.0000
sub.trial.number8 - sub.trial.number13 -207.0517 18.7 Inf -11.059 <.0001
sub.trial.number8 - sub.trial.number14 -81.9205 18.7 Inf -4.376 0.0017
sub.trial.number8 - sub.trial.number15 -25.2843 18.7 Inf -1.351 0.9972
sub.trial.number8 - sub.trial.number16 39.9205 18.7 Inf 2.132 0.7975
sub.trial.number8 - sub.trial.number17 -11.4095 18.7 Inf -0.609 1.0000
sub.trial.number8 - sub.trial.number18 0.0895 18.7 Inf 0.005 1.0000
sub.trial.number9 - sub.trial.number10 -13.5765 18.7 Inf -0.725 1.0000
sub.trial.number9 - sub.trial.number11 22.9801 18.7 Inf 1.227 0.9991
sub.trial.number9 - sub.trial.number12 65.3996 18.7 Inf 3.493 0.0493
sub.trial.number9 - sub.trial.number13 -149.4592 18.7 Inf -7.983 <.0001
sub.trial.number9 - sub.trial.number14 -24.3280 18.7 Inf -1.299 0.9983
sub.trial.number9 - sub.trial.number15 32.3082 18.7 Inf 1.726 0.9620
sub.trial.number9 - sub.trial.number16 97.5129 18.7 Inf 5.208 <.0001
sub.trial.number9 - sub.trial.number17 46.1829 18.7 Inf 2.467 0.5561
sub.trial.number9 - sub.trial.number18 57.6819 18.7 Inf 3.081 0.1633
sub.trial.number10 - sub.trial.number11 36.5567 18.7 Inf 1.953 0.8913
sub.trial.number10 - sub.trial.number12 78.9761 18.7 Inf 4.218 0.0033
sub.trial.number10 - sub.trial.number13 -135.8827 18.7 Inf -7.258 <.0001
sub.trial.number10 - sub.trial.number14 -10.7515 18.7 Inf -0.574 1.0000
sub.trial.number10 - sub.trial.number15 45.8847 18.7 Inf 2.451 0.5685
sub.trial.number10 - sub.trial.number16 111.0895 18.7 Inf 5.934 <.0001
sub.trial.number10 - sub.trial.number17 59.7594 18.7 Inf 3.192 0.1216
sub.trial.number10 - sub.trial.number18 71.2584 18.7 Inf 3.806 0.0167
sub.trial.number11 - sub.trial.number12 42.4195 18.7 Inf 2.266 0.7084
sub.trial.number11 - sub.trial.number13 -172.4394 18.7 Inf -9.211 <.0001
sub.trial.number11 - sub.trial.number14 -47.3082 18.7 Inf -2.527 0.5094
sub.trial.number11 - sub.trial.number15 9.3280 18.7 Inf 0.498 1.0000
sub.trial.number11 - sub.trial.number16 74.5328 18.7 Inf 3.981 0.0086
sub.trial.number11 - sub.trial.number17 23.2028 18.7 Inf 1.239 0.9990
sub.trial.number11 - sub.trial.number18 34.7018 18.7 Inf 1.854 0.9285
sub.trial.number12 - sub.trial.number13 -214.8588 18.7 Inf -11.476 <.0001
sub.trial.number12 - sub.trial.number14 -89.7276 18.7 Inf -4.793 0.0002
sub.trial.number12 - sub.trial.number15 -33.0915 18.7 Inf -1.768 0.9527
sub.trial.number12 - sub.trial.number16 32.1133 18.7 Inf 1.715 0.9641
sub.trial.number12 - sub.trial.number17 -19.2167 18.7 Inf -1.026 0.9999
sub.trial.number12 - sub.trial.number18 -7.7177 18.7 Inf -0.412 1.0000
sub.trial.number13 - sub.trial.number14 125.1312 18.7 Inf 6.684 <.0001
sub.trial.number13 - sub.trial.number15 181.7674 18.7 Inf 9.709 <.0001
sub.trial.number13 - sub.trial.number16 246.9722 18.7 Inf 13.192 <.0001
sub.trial.number13 - sub.trial.number17 195.6421 18.7 Inf 10.450 <.0001
sub.trial.number13 - sub.trial.number18 207.1412 18.7 Inf 11.064 <.0001
sub.trial.number14 - sub.trial.number15 56.6362 18.7 Inf 3.025 0.1880
sub.trial.number14 - sub.trial.number16 121.8410 18.7 Inf 6.508 <.0001
sub.trial.number14 - sub.trial.number17 70.5109 18.7 Inf 3.766 0.0193
sub.trial.number14 - sub.trial.number18 82.0099 18.7 Inf 4.380 0.0016
sub.trial.number15 - sub.trial.number16 65.2048 18.7 Inf 3.483 0.0510
sub.trial.number15 - sub.trial.number17 13.8748 18.7 Inf 0.741 1.0000
sub.trial.number15 - sub.trial.number18 25.3738 18.7 Inf 1.355 0.9971
sub.trial.number16 - sub.trial.number17 -51.3300 18.7 Inf -2.742 0.3512
sub.trial.number16 - sub.trial.number18 -39.8310 18.7 Inf -2.127 0.8004
sub.trial.number17 - sub.trial.number18 11.4990 18.7 Inf 0.614 1.0000
Degrees-of-freedom method: asymptotic
P value adjustment: tukey method for comparing a family of 18 estimates
There seems to be significant spike in RT at the 13th step of the sequence. There is a significant difference between the 13th step and all others( p< 0.001). Especially, the 13th step has a 216.71ms slower RT than step 12 and a 125.291ms slower RT than step 14. This seems to indicate that there could be a concatenation point step 13.
df_acc <- df_acc %>% mutate (session= as.factor (session))
M3 <- lmer (feedback.RT~ session + (1 | subject) + (1 | trial)+ (1 | corr_trials), data = df_acc)
ae.m.M3 <- allEffects (M3)
ae.m.M3.df <- as.data.frame (ae.m.M3[1 ])
plot (ae.m.M3)
Analysis of Deviance Table (Type II Wald chisquare tests)
Response: feedback.RT
Chisq Df Pr(>Chisq)
session 58.46 2 2.021e-13 ***
---
Signif. codes: 0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1
Linear mixed model fit by REML ['lmerMod']
Formula:
feedback.RT ~ session + (1 | subject) + (1 | trial) + (1 | corr_trials)
Data: df_acc
REML criterion at convergence: 285576.9
Scaled residuals:
Min 1Q Median 3Q Max
-3.174 -0.484 -0.205 0.212 33.103
Random effects:
Groups Name Variance Std.Dev.
trial (Intercept) 2997 54.75
corr_trials (Intercept) 10587 102.90
subject (Intercept) 36021 189.79
Residual 92568 304.25
Number of obs: 19992, groups: trial, 48; corr_trials, 19; subject, 19
Fixed effects:
Estimate Std. Error t value
(Intercept) 490.531 50.381 9.736
session2 -10.600 6.032 -1.757
session3 26.739 5.840 4.578
Correlation of Fixed Effects:
(Intr) sessn2
session2 -0.072
session3 -0.077 0.642
posthoc3 <- emmeans (M3, ~ session)
Note: D.f. calculations have been disabled because the number of observations exceeds 3000.
To enable adjustments, add the argument 'pbkrtest.limit = 19992' (or larger)
[or, globally, 'set emm_options(pbkrtest.limit = 19992)' or larger];
but be warned that this may result in large computation time and memory use.
Note: D.f. calculations have been disabled because the number of observations exceeds 3000.
To enable adjustments, add the argument 'lmerTest.limit = 19992' (or larger)
[or, globally, 'set emm_options(lmerTest.limit = 19992)' or larger];
but be warned that this may result in large computation time and memory use.
pairwise_comparisons3 <- pairs (posthoc3)
summary (pairwise_comparisons3)
contrast estimate SE df z.ratio p.value
session1 - session2 10.6 6.03 Inf 1.757 0.1842
session1 - session3 -26.7 5.84 Inf -4.578 <.0001
session2 - session3 -37.3 5.03 Inf -7.427 <.0001
Degrees-of-freedom method: asymptotic
P value adjustment: tukey method for comparing a family of 3 estimates
No significant differnece in RT between session 1 and 2. Session 3 is 35 ms faster than session 1 and 36ms faster than session 2 (p<0.0001.)
df_questionaire <- df_after_session_qestionaire %>% select (session, subject, mental_demand,physical_demand,temporal_demand,frustration,performance,effort) %>% group_by (session,subject) %>% slice (1 )
# Summarize data: calculate mean x and y for each session
df_summary <- df_after_session_qestionaire %>%
group_by (session) %>%
summarise (mean_x = mean (x, na.rm = TRUE ),
mean_y = mean (y, na.rm = TRUE ))
#3
x_limits <- c (- 300 , 300 )
y_limits <- c (- 300 , 300 )
ggplot (df_summary, aes (x = mean_x, y = mean_y, color = as.factor (session))) +
# Plot the mean points for each session
geom_point (size = 4 ) +
# Add thick lines for the zero axes
geom_vline (xintercept = 0 , size = 1.2 , color = "black" ) +
geom_hline (yintercept = 0 , size = 1.2 , color = "black" ) +
# Set custom axis limits and tick labels
scale_x_continuous (limits = x_limits, breaks = c (x_limits[1 ], 0 , x_limits[2 ]),
labels = c ("Unpleasant feelings" , "0" , "Pleasant feelings" )) +
scale_y_continuous (limits = y_limits, breaks = c (y_limits[1 ], 0 , y_limits[2 ]),
labels = c ("Sleepiness" , "0" , "High arousal" )) +
labs (x = "" , y = "" , color = "Session" ) +
theme_minimal () +
theme (
axis.line = element_line (color = "black" , size = 1 ), # Emphasize the axes lines
panel.grid.minor = element_blank ()
)
Warning: Using `size` aesthetic for lines was deprecated in ggplot2 3.4.0.
ℹ Please use `linewidth` instead.
Warning: The `size` argument of `element_line()` is deprecated as of ggplot2 3.4.0.
ℹ Please use the `linewidth` argument instead.
M4 <- lmer (mental_demand ~ session + (1 | subject) , data = df_q_long2)
#Checking if you have a main effect
Anova (M4)
Analysis of Deviance Table (Type II Wald chisquare tests)
Response: mental_demand
Chisq Df Pr(>Chisq)
session 50.687 4 2.595e-10 ***
---
Signif. codes: 0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1
#Effects
ae.m.M4 <- allEffects (M4)
ae.m.M4.df <- as.data.frame (ae.m.M4[1 ])
ae.m.M4$ session <- factor (ae.m.M4$ session, ordered = TRUE , levels= c ('B' ,'1' ,'2' ,'3' ,'4' ))
plot (ae.m.M4)
Warning in plot.window(xlim, ylim, log = log, ...): "lattice" is not a
graphical parameter
Warning in axis(if (horiz) 2 else 1, at = at.l, labels = names.arg, lty =
axis.lty, : "lattice" is not a graphical parameter
Warning in title(main = main, sub = sub, xlab = xlab, ylab = ylab, ...):
"lattice" is not a graphical parameter
Warning in axis(if (horiz) 1 else 2, cex.axis = cex.axis, ...): "lattice" is
not a graphical parameter
[,1]
[1,] 0.7
[2,] 1.9
[3,] 3.1
[4,] 4.3
[5,] 5.5
df_q_long2 <- df_q_long2 %>%
separate (C, into = c ("x1" , "y2" ), sep = "/" , convert = TRUE ) %>% mutate (x1= as.numeric (x1),y2 = as.numeric (y2))
Warning: Expected 2 pieces. Additional pieces discarded in 7 rows [2, 5, 20, 30, 55, 82,
90].
Warning: Expected 2 pieces. Missing pieces filled with `NA` in 2 rows [65, 95].
Warning: There were 2 warnings in `mutate()`.
The first warning was:
ℹ In argument: `x1 = as.numeric(x1)`.
Caused by warning:
! NAs introduced by coercion
ℹ Run `dplyr::last_dplyr_warnings()` to see the 1 remaining warning.
M11 <- lmer (x ~ session + (1 | subject) + (1 | session) , data = df_q_long2)
Warning in checkConv(attr(opt, "derivs"), opt$par, ctrl = control$checkConv, :
unable to evaluate scaled gradient
Warning in checkConv(attr(opt, "derivs"), opt$par, ctrl = control$checkConv, :
Hessian is numerically singular: parameters are not uniquely determined
Analysis of Deviance Table (Type II Wald chisquare tests)
Response: x
Chisq Df Pr(>Chisq)
session 1.6071 4 0.8075
If the baseline is used to compare against it can be seen that for most measures, block 3 is the most challenging. Mental demand, physical demand effort and frustration are the highest in this block when compared to baseline. temporal demand is slightly higher in block 2 and people percieve their performance as the highest in block 4